Community Acquired Pneumonia

Community Acquired Pneumonia

  • Immunosuppression
  • Acute exacerbation of COPD
  • Bronchitis
  • Macro-aspiration
  • Chronic pneumonia syndrome (pneumonia symptoms lasting more than 3 weeks)
  • Cystic fibrosis
  • Bronchiectasis
  • MRSA

Choose All That Apply

More Information

Guideline content derived from:

  • NB Provincial Health Authorities Anti-Infective Stewardship Committee. Antimicrobial Therapy for Adult Community Acquired Pneumonia (CAP). 05-2018
  1. Kolditz M et al. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med, 2015. 278: 193-202
  2. Horita N et al. Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis. Respirology. 2016; 21(7): 1193-200
  3. Woodhead M et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect 2011; 17(suppl. 6): E1-59
  4. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet 2015;386: 1097-1108
  5. Musher DM and Thorner AR. Community-Acquired Pneumonia. N Engl J Med 2014; 371; 71: 1619-1628
  6. Pletz MW et al. Advances in the prevention, management, and treatment of community-acquired pneumonia. F1000 Research 2016, 5(F1000 Faculty Rev): 300
  7. Lee JS et al. Antibiotic Therapy for Adults Hospitalized With Community Acquired Pneumonia: A Systematic Review. JAMA. 2016; 315 (6): 593-602
  8. Toronto Central LHIN Emergency Department Algorithm. Pneumonia: Community-Acquired. 2013.
  9. Miyashita N et al. Is it possible to distinguish between atypical pneumonia and bacterial pneumonia. Respiratory Medicine. 2004; 98: 952-960
  10. Miyashita N et al. The JRS Guidelines for the Management of Community-Acquired Pneumonia in Adults: An Update and New Recommendations. Intern Med. 2006; 45(7): 419-428
  11. Yin Y et al. Evaluation of the JRS guidelines for the identification of Mycoplasma pneumoniae pneumonia. Respirology. 2012; 17(7): 1131-1136
  12. Uranga et al. Duration of Antibiotic Treatment in Community-Acquired Pneumonia. JAMA Intern Med. 2016; 176 (9): 1257-1265
  13. Lee JS et al. Duration of Antibiotic Therapy for Community-Acquired Pneumonia in the Era of Personalized Medicine. JAMA. 2016; 316 (23): 2544-2545
  14. Cooper et al. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimicrob Chemother. 1985 Sep;16(3):373-8.
  15. Revest M et al. Adjuvant corticosteroids for patients hospitalized with community acquired pneumonia: is it time? J Thorac Dis 2016;8(5):E288-E291
  16. Mandell LA et al. IDSA/ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S27–72
  17. Mandell LA, et al. Summary of Canadian Guidelines for the Initial Management of Community-acquired Pneumonia: An evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can J Infect Dis. 2000 Sep-Oct; 11(5): 237–248